Heart Rate Variability and Anxiety During Urinary Bladder Catheterization
Launched by UNIVERSITY OF BRITISH COLUMBIA · May 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the experience of using a urinary catheter affects both the physical and emotional well-being of adults who have suffered a spinal cord injury (SCI). Researchers want to understand how anxiety levels and heart rate variability change during the process of intermittent catheterization, which is a method used to help manage urinary drainage in these individuals.
To participate in this study, you need to be between 18 and 70 years old and have a chronic spinal cord injury that affects your ability to sense or move (either completely or partially). You should have been injured for at least a year and be able to manage the catheter yourself. If you are currently experiencing a urinary tract infection or have certain medical conditions, you may not be eligible. Participants will be asked to visit the clinic and fill out questionnaires about their experiences. This study aims to improve our understanding of how to better support individuals with spinal cord injuries during catheterization, making the process less stressful for them.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female, 18-70 years of age
- • Any chronic traumatic SCI with either motor sensory complete injury (AIS A/B, N=10) or motor sensory incomplete injury (AIS B/D, N=10).
- • At least 1 year post injury, and at least 6 months from any spinal surgery
- • Hand function sufficient to perform intermittent catheterization for management of urinary bladder drainage
- • Must provide informed consent and be able to understand and complete study-related questionnaires (must be able to understand and speak English or have access to an appropriate interpreter as judged by the investigator)
- • Willing and able to comply with clinic visit and study-related procedures
- Exclusion Criteria:
- • Signs or known current urinary tract infection, or other inflammatory conditions of bladder/urethra
- • Currently taking beta blockers or other medications that may affect heart rate
- • History of ureteral injury
- • History of any urinary diversion procedures, including but not limited to bladder augmentation, cystectomy, neo bladder, pouch reservoir, ileal conduit, Mitrofanoff appendicovesicostomy
- • For women of childbearing potential, currently pregnant
- • A member of the investigational team or his/her immediate family Presence of severe acute medical issue and use of any specific medication or treatment that, in the investigator's judgement, would adversely affect the participant's participation in the study
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Andrei Krassioukov, MD,PhD,FRCPC
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials